Intellectual Property

2025 Trade Secrets Webinar Series

REGISTER HERE

Thursday, May 1, 20251:00 p.m. to 2:00 p.m. Eastern12:00 p.m. to 1:00 p.m. Central11:00 a.m. to 12:00 p.m. Mountain10:00 a.m. to 11:00 a.m. Pacific

About the Program

In today’s always-online world, a single social media post, GitHub upload, or Slack message can put millions of dollars in proprietary

New and emerging technology is always exciting and interesting to learn. Traverse Legal’s attorneys have always prided themselves on understanding the underlying technology for emerging industries such as blockchain and crypto. As importantly, the rapid rise of cryptocurrencies and blockchain technology has created an entirely new category of legal work. Crypto law is not

AI startups face a unique paradox: while innovation can happen overnight, legal clarity often takes months—and not getting it right can cost you everything. Whether you’re building proprietary LLM infrastructure, training models on licensed datasets, or deploying AI-driven tools for end users, the stakes are high. Legal mistakes in the early days may not show

U.S.-China Trade War: A Zero-Sum Game Doomed to Fail?How tariffs, rare earth bans, and game theory are reshaping global trade.

Game theory posits that rational actors will act in their self interest to maximize their aims, but will back down when factors no longer preserve their self interest. Or if the actors do not trust each other,

IPNews® – A federal appeals court recently affirmed that images produced by artificial intelligence cannot receive copyright protection. 

This leaves AI artists with little to no recourse if a work they create is infringed. This may feel a little unfair to artists who create works while using AI. To continue reading, click: Lack of Copyright Protection

Tuesday, May 6, 20251:00 p.m. to 2:00 p.m. Eastern12:00 p.m. to 1:00 p.m. Central11:00 a.m. to 12:00 p.m. Mountain10:00 a.m. to 11:00 a.m. Pacific

Register Here

About the Program

Join us for the third and final session of our Commercial Litigation Outlook webinar series, where we’ll examine key legal trends shaping the future of trade


On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced it will be phasing out the current requirements for animal testing in the development of monoclonal antibody therapies and other drugs, replacing them “with more effective, human-relevant methods.”  According to the FDA, the “animal testing requirement will be reduced, refined, or potentially replaced